The field of engineering has made substantial strides in nanotechnology, in the realm of materials science and construction of nanoscale devices. Nanomedicine encompasses application of cutting edge engineered nanostructures to biological systems and development of novel strategies for disease intervention. In the current review, we discuss the pharmacological application of nanoparticles as free radical scavengers and the capacity of nanoparticles to promote cell and organismal longevity.
OberdorsterG., OberdorsterE., OberdorsterA.Nanotoxicology: An Emerging Discipline Evolving from Studies of Ultrafine Particles. Env. Health Persp.113, 823–839 (2005).
ToescuE. C., VerkhratskyA.Neuronal Aging from an Intraneuronal Perspective: Roles of Endoplasmic Reticulum and Mitochondria. Cell Ca.34, 311–323 (2005).
9.
MashimaR., WittingP. K., StockerR.Oxidants and Antioxidants in Atherosclerosis. Curr. Op. Lipidol.12, 411–418 (2001).
AzbilR. D., MuX., Bruce-KellerA. J., MattsonM. P., and SpringerJ. E.Impaired Mitochondrial Function, Oxidative Stress and Altered Antioxidant Enzyme Activities Following Traumatic Spinal Cord Injury. Brain Res.765, 283–290 (1997).
12.
TortorellaC., PiazollaG., and AntonaciS.Neutrophil Oxidative Metabolism in Aged Humans: A Perspective. Immunopharmacol. Immunotoxicol.23, 565–572 (2001).
13.
SmithW. L.Prostanoid Biosynthesis and Mechanisms of Action. Am. J. Physiol.263, F181–F191 (1992).
14.
MarchioliR., SchweigerC., LevantesiG., TavazziL., and ValagussaF.Antioxidant Vitamins and Prevention of Cardio-vascular Disease: Epidemiological and Clinical Trial Data. Lipids36, S53–S63 (2001).
15.
MeldrumB. S.Implications for Neuroprotective Treatments. Prog. Brain Res.135, 487–495 (2002).
16.
MaxwellA. J.Mechanisms of Dysfunction of the Nitric Oxide Pathway in Vascular Diseases. Nitric Ox.6, 101–124 (2002).
17.
CarneyJ. M., Starke-ReedP. E., OliverC. N., LandumR. W., ChengM. S., WuJ. F., and FloydR. A.Reversal of Age-related Increase in Brain Protein Oxidation, Decrease in Enzyme Activity, and Loss in Temporal and Spatial Memory by Chronic Administration of the Spin-trapping Compound N-tert-butyl-alpha-phenylnitrone. Proc. Natl. Acad. Sci. USA88, 3633–3636 (1991).
18.
SmithC. D., CarneyJ. M., Starke-ReedP. E., OliverC. N., StadtmanE. R., FloydR. A., and MarkesberyW. R.Excess Brain Protein Oxidation and Enzyme Dysfunction in Normal Aging and in Alzheimer's Disease. Proc. Natl. Acad. Sci. USA88, 10540–10543 (1991).
19.
SohalR. S.Role of Oxidative Stress and Protein Oxidation in the Aging Process. Free Rad. Biol. Med.33, 37–44 (2002).
20.
SzwedaP. A., FriguetB., and SzwedaL. I.Proteolysis, Free Radicals, and Aging. Free Rad. Biol. Med.33, 29–36 (2002).
21.
FriguetB., BulteauA. L., ChondrogianniN., ConconiM., and PetropoulosI.Protein Degradation by the Proteasome and its Implications in Aging. Ann. NY Acad. Sci908, 143–154 (2000).
22.
GruneT. and DaviesK. J.Oxidative Processes in Aging. In Handbook of the Biology of Aging, p. 25–58. Eds., MasoroE. J. and AustadS. N.San Diego, Academic Press (2001).
23.
ButterfieldD. A., DrakeJ., PocernichC., and CastegnaA.Evidence of Oxidative Damage in Alzheimer's Disease Brain: Central Role for Amyloid Beta-peptide. Trends Mol. Med.7, 548–554 (2001).
24.
HadleyE. C., LakattaE. G., Morrison-BogoradM., WarnerH. R., HodesR. J.The Future of Aging Therapies. Cell129, 557–567 (2005).
25.
HarmanD.Aging: A Theory Based on Free Radical and Radiation Chemistry. J. Gerontol.11, 298–300 (1956).
26.
HarmanD.Aging: Overview. Ann. NY Acad. Sci.928, 1–21 (2001).
27.
CoskunP. E., LadigesW., WolfN., RemmenH. V., WallaceD. C., and RabinovitchP. S.Extension of Murine Life Span by Overexpression of Catalase Targeted to Mitochondria. Science308, 1910–1911 (2005).
28.
SalveminiD., RipleyD. P., and CuzzocreaS.SOD Mimetics are Coming of Age. Nat. Rev. Drug Discov.1, 367–374 (2002).
29.
LekerR. R. and ShohamiE.Cerebral Ischemia and Trauma-Different Etiologies Yet Similar Mechanisms: Neuroprotective Opportunities. Brain Res. Brain Res. Rev.39, 55–73 (2002).
30.
EvansC. H.Biochemistry of the Lanthanides, Plenum Press, NY (1990).
31.
LandP. L.Defect Equilibria for Extended Point Defects, with Application to Nanostochiometric Ceria. J. Phys. Chem. Solids34, 1839–1845 (1973).
32.
SuzukiK. T., KosackiI., and AndersonH. U.Electrical Conductivity and Lattice Defects in Nanocrystalline Cerium Oxide Thin Films. J. Amer. Ceram. Soc.84, 2007–2014 (2001).
33.
DavisV. T.Measurement of the Electron Affinity of Cerium. Phys. Rev. Lett.88, 1–4 (2002).
34.
HermanG. S.Characterization of Surface Defects on Epitaxial CeO2 (001) Films. Surface Sci.437, 207–214 (1999).
35.
ConesaJ. C.Computer Modeling of Surfaces and Defects on Cerium Dioxide. Surface Sci.339, 337–352 (1995).
36.
HeinemannC., CornehlH. H., SchroderD., DolgM., and SchwarzH.The CeO2+ Cation: Gas-phase Reactivity and Electronic Structure. Inorg. Chem.35, 2463–2475 (1996).
37.
FashuiH.Study on the Mechanism of Cerium Nitrate Effects on Germination of Aged Rice Seed. Biol. Trace Elem. Res.87, 191–200 (2002).
38.
HeM. L., RanzD., and RambeckW. A.Study on the Performance Enhancing Effect of Rare Earth Elements in Growing and Fattening Pigs. J. An. Phys. and An. Nutr.85, 263–274 (2001).
39.
GarnerJ. P., HeppellP. S. J.The Use of Flammacerium in British Burns Units. Burns31, 379–382 (2005).
40.
TelekG., ScoazecJ.-Y., ChariotJ., DucrocR., FeldmannG., and RozeC.Cerium-based Histochemical Demonstration of Oxidative Stress in Taurocholate-induced Acute Pancreatitis in Rats: A Confocal Laser Scanning Microscopic Study. J. Histochem. Cytochem.47, 1202–1212 (1999).
41.
BaileyD., ChowL., MerchantS., KuiryS. C., PatilS., SealS., and RzigalinskiB. A.Cerium Oxide Nanoparticles Extend Cell Longevity and Act as Free Radical Scavengers. Nature Biotechnol. 14, 112 (2003).
42.
ClarkA., EllisonA., FryR., MerchantS., KuiryS., PatilS., SealS., and RzigalinskiB. A.Engineered Oxide Nanoparticles Increase Neuronal Lifespan in Culture and Act as Free Radical Scavengers. Neuroscience878. 2 (2003).
43.
AhmedS. M., RzigalinskiB. A., WilloughbyK. A., and EllisE. F.Alterations in Mitochondrial Energetics after In Vitro Traumatic Injury of Astrocytes and Neurons. J. Neurochem.74, 289–299 (1999).
44.
WeberJ. T., RzigalinskiB. A., and EllisE. F.Traumatic Injury of Cortical Neurons Causes Changes in Intracellular Free Calcium Stores and Capacitative Calcium Influx. J. Biol. Chem.276, 1800–1807 (2001).
45.
AhmedS. M., WeberJ. T., LiangS., WilloughbyK. A., SitterdingH. A., RzigalinskiB. A., and EllisE. F.NMDA Receptor Activation Contributes to Elevated Intracellular Calcium and Decreased Mitochondrial Membrane Potential in Stretch-injured Neurons. J. Neurotrauma12, 619–629 (2002).
46.
WeberJ. T., RzigalinskiB. A., and EllisE. F.Calcium Responses to Caffeine and Muscarinic Receptor Agonists are Altered in Traumatically Injured Neurons. J. Neurotrauma11, 1433–1443 (2002).
47.
ZhangL., RzigalinskiB. A., EllisE. F., and SatinL. S.Reduction of Voltage-dependent Mg2+ Blockade of NMDA Currents in Mechanically Injured Cortical Neurons. Science274, 1921–1923 (1997).
48.
HoffmanS. W., RzigalinskiB. A., WilloughbyK. A., and EllisE. F.Astrocytes Generate Isoprostanes in Response to Trauma or Oxygen Radicals. J. Neurotrauma28, 844–849 (2000).
49.
LambR. G., HarperC. C., McKinneyJ. S., RzigalinskiB. A., and EllisE. F.Alterations in Phosphatidylcholine Metabolism of Stretch-injured Cultured Rat Astrocytes. J. Neurochem.68, 1904–1910 (1997).
50.
FryR., EllisonA., ColonJ., MerchantS., KuiryS., PatilS., SealS., and RzigalinskiB. A.Engineered Oxide Nanoparticles Protect Against Neuronal Damage Associated with In Vitro Trauma. J. Neurotrauma20, 1054 (2003).
51.
CallaghanP., ColonJ., MerchantS., KuiryS., PatilS., SealS., and RzigalinskiB. A.Deleterious Effects of Microglia Activated by In Vitro Trauma are Blocked by Engineered Oxide Nanoparticles. J. Neurotrauma20, 1053 (2003).
52.
AneggiE., BoaroM., de LeitenburgC., DolcettiG., and TrovarellisA.Insights into the Redox Properties of Ceria-based Oxides and Their Implications in Catalysis. J. Alloys Compds. In Press (2005).
53.
TrovarelliA.Catalysis by Ceria and Related Materials. Imperial College Press, London (2002).
54.
SatoS., TakahashiR., SodesawaT., and HondaN.Dehydration of Diols Catalyzed by CeO2. J. Molec. Catal. A221, 177–183 (2004).
55.
de LorenzoA. J.The Olfactory Neuron and the Blood-brain Barrier. In: Taste & Smell in Vertebrates, p. 151–176. Eds., WolstenholmeG. and KnightJ.London, Churchill (1970).
56.
RejmanJ., OberleV., ZuhornI. S., HoekstraD.Size-dependent Internalization of Particles via the Pathways of Clathrin-and Caveolae-mediated Endocytosis. Biochem J.377, 159–169 (2004).
57.
Corona-MoralesA. A., CastellA., EscobarA., and Drucker-ColfinR.Fullerene C60 and Ascorbic Acid Protect Cultured Chromaffin Cells Against Levodopa Toxicity. J. Neurosci. Res.71, 121–126 (2003).
DuganL. L., GabrielesenJ. K., YuS. P., LinT. S., ChoiD. W.Buckminsterfullerenol Free Radical Scavengers Reduce Excitotoxic and Apoptotic Death of Cultured Cortical Neurons. Neurobiol. Dis.3, 129–135 (1996).
60.
DuganL. L., TuretskyD. M., DuC., LobnerD., WheelerM., AlmliC. R., ShenC. K., LuhT. Y., ChoiD. W., and LinT. S.Carboxyfullerenes as Neuroprotective Agents. Proc. Natl. Acad. Sci. USA.94, 9434–9439 (1997).
61.
LinA. M. Y., ChyiB. Y., WangS. D., YuH.-H., KanakammaP. P., LuhT.-Y., ChouC. K., and HoL. T.Carboxyfullerene Prevents Iron-induced Oxidative Stress in Rat Brain. J. Neurochem.72, 1634–1640 (1999).
62.
TonksN. K.Redox Redux: Revisiting PTPs and the Control of Cell Signaling. Cell121, 667–670 (2005).
63.
SatohM., MatsuoK., KiriyaH., MashinoT., NaganoT., HirobeM., and TakayanagiI.. Inhibitory Effects of Fullerene Derivative Dimalonic Acid C60, on Nitric Oxide-Induced Relaxation of Rabbit Aorta. Eur. J. Pharm.327, 175–181 (1997).
64.
ShvedovaA. A. and CastranovaV.Exposure to Carbon Nanotube Material: Assessment of Nanotube Cytotoxicity Using Human Keratinocyte Cells. J. Tox. Env. Health66, 1909–1926 (2003).
65.
Da RosT. and PratoM.Medicinal Chemistry with Fullerenes and Fullerene Derivatives. Chem. Commun.8, 663–669 (1999).
